<DOC>
	<DOCNO>NCT01212874</DOCNO>
	<brief_summary>This investigator initiate , sponsor , open label , prospective randomize control trial perform adult patient undergo scheduled cardiac surgery . Patients randomize esmolol infusion nitroglycerin infusion control hypertension occur cardiac surgery induction anesthesia initiation cardiopulmonary bypass ( CPB ) .</brief_summary>
	<brief_title>Esmolol Nitroglycerin Infusion Blood Pressure Control Prior Cardiopulmonary Bypass ( CPB ) Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Nitroglycerin</mesh_term>
	<mesh_term>Esmolol</mesh_term>
	<criteria>adult patient schedule cardiac surgery LLUMC University Hospital eligible participation study . 1. severe LV ( left ventricle ) dysfunction ( EF &lt; 35 % ) . 2. emergency procedure . 3. procedure combine carotid artery surgery . 4. patient high risk stroke . 5. hemodynamically significant dysrhythmias . 6. preexist atrial fibrillation high degree AV ( atrioventricular block ) . 7. pacemaker dependency . 8. known sensitivity beta blocker . 9. patient refusal .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>